Polyglucose solutions in CAPD.
Wilkie
M E
ME
Sheffield Kidney Institute, Northern General Hospital NHS, United Kingdom.
Brown
C B
CB
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003928:Diabetic Nephropathies / Q000628:therapy*; D015314:Dialysis Solutions / Q000009:adverse effects; D005260:Female; D005936:Glucans / Q000009:adverse effects; D005947:Glucose / Q000009:adverse effects; D006801:Humans; D000077607:Icodextrin; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis; D016019:Survival Analysis; D017211:Treatment Failure; D014462:Ultrafiltration
D015314:Dialysis Solutions; D005936:Glucans; D000077607:Icodextrin; D005947:Glucose